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Melanoma is the most aggressive skin cancer. The speciﬁcity and sensitivity of clinical diagnosis varies from
around 40% to 80%. Here, we investigated whether the chemical changes in the melanoma tissue detected by
Raman spectroscopy and neural networks can be used for diagnostic purposes. Near-infrared Fourier transform
Raman spectra were obtained from samples of melanoma (n¼ 22) and other skin tumors that can be clinically
confused with melanoma: pigmented nevi (n¼ 41), basal cell carcinoma (n¼ 48), seborrheic keratoses (n¼ 23), and
normal skin (n¼ 89). A sensitivity analysis of spectral frequencies used by a neural network was performed to
determine the importance of the individual components in the Raman spectra. Visual inspection of the Raman
spectra suggested that melanoma could be differentiated from pigmented nevi, basal cell carcinoma, seborrheic
keratoses, and normal skin due to the decrease in the intensity of the amide I protein band around 1660 cm1.
Moreover, melanoma and basal cell carcinoma showed an increase in the intensity of the lipid-speciﬁc band peaks
around 1310 cm1 and 1330 cm1, respectively. Band alterations used in the visual inspection were also
independently identiﬁed by a neural network for melanoma diagnosis. The sensitivity and speciﬁcity for diagnosis
of melanoma achieved by neural network analysis of Raman spectra were 85% and 99%, respectively. We propose
that neural network analysis of near-infrared Fourier transform Raman spectra could provide a novel method for
rapid, automated skin cancer diagnosis on unstained skin samples.
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Melanoma (MM) is the most aggressive of skin cancers and
is invariably fatal if left untreated (MacKie, 2000; Marks,
2000; Martinez and Otley, 2001). MM removal at early
stages is almost always curative and therefore early
detection is essential. Clinical diagnostic sensitivity differs
greatly depending on the length of training of the clinician:
80% for trained dermatologists, 62% for senior registrars,
56% for registrars, and approximately 40% for nonderma-
tologists (Cassileth et al, 1986; Morton and Mackie, 1998;
Chen et al, 2001).
Difficulties in diagnosis of cutaneous MM arise because
benign lesions like pigmented nevi (PN), seborrheic kera-
tosis (SK), and other types of skin cancer such as basal cell
carcinoma (BCC) may resemble melanoma (MacKie, 2000;
Kanzler and Mraz-Genrnhard, 2001). Histopathologic ex-
amination of the excised suspicious element is considered
to be the golden standard (Slater, 2000). Removal of every
pigmented lesion is unacceptable for the patient, however,
especially in the case of multiple skin lesions or lesions
localized in cosmetically important parts of the body such
as the face because of risk of scarring. Eighty percent of
biopsies taken by nondermatologists of suspected malig-
nant skin lesions have been reported to be benign (Jones
et al, 1996) and thus inappropriate surgery is frequent (Cox
et al, 1992).
Development of noninvasive diagnostic methods is
therefore crucial for MM detection. Despite many attempts
to implement various instrumental techniques (total body
photography, dermatoscopy, high-frequency skin ultraso-
nography, fluorescence spectroscopy, positron emission
tomography, etc.) a noninvasive, reliable method for MM
diagnosis has not yet been established (Harland et al, 2000;
Bafounta et al, 2001; Kittler et al, 2002; Prichard et al, 2002).
Raman spectroscopy is a technique that provides
information about the molecular structure of the investi-
gated sample and has been widely used for the past 70 y for
nondestructive chemical analysis (Raman and Krishanan,
1928; Edwards et al, 1995; Hanlon et al, 2000; Puppels et al,
2001). In Raman spectroscopy a sample is irradiated with
laser light, which results in light scattering. The majority of
Abbreviations: MM, melanoma; NIR-FT, near-infrared Fourier
transform; PN, pigmented nevi; SK, seborrheic keratosis.
Copyright r 2004 by The Society for Investigative Dermatology, Inc.
443
scattered light has unchanged frequency (so-called Ray-
leigh line) whereas the rest is shifted in frequency (Raman
effect). The frequency shifts can be analyzed and presented
as a Raman spectrum. The Raman effect is caused by
molecular vibrations in the irradiated sample and thus gives
information about the structure of the molecules. Molecular
vibrations can be divided into deformational vibrations
where the angles between the bonds change, and stretch-
ing vibrations where the lengths of the bonds change but
the angle between them remains constant.
Previous studies of samples obtained from the genital
tract, brain, breast, and larynx revealed that the transition
from normal to cancer tissue is associated with significant
differences in chemical structure, which are reflected in the
Raman spectra (Liu et al, 1992; Mizuno et al, 1994; Hanlon
et al, 2000; Stone et al, 2000). Benign and malignant
changes in the gastrointestinal tract have recently been
studied intraoperatively in vivo with the aid of Raman
spectroscopy (Shim et al, 2000; Dacosta et al, 2002).
Our earlier studies have shown that samples of various
benign skin lesions and nonmelanoma skin cancer have
characteristic Raman spectra (Gniadecka et al, 1997a;
1997b; 1998a) and that this technique is highly reproducible
(Gniadecka et al, 1998b). Recent studies on BCC by Raman
spectroscopy showed that it is feasible to differentiate
malignant tissue from the healthy surrounding tissue
(Nijssen et al, 2002).
Raman spectra are complex and the traditional inter-
pretation of the spectra by their visual inspection is
subjective and time consuming. Artificial neural networks
are a pattern recognition tool for modeling nonlinear
functional relationships in data. Neural networks may be
applied to problems where the relationship is complex or
unknown. Automated computer methods like principal
component analysis and neural networks have been devel-
oped in the last decades for many different applications in
biomedical research (Hanlon et al, 2000; Christoyianni et al,
2002; Dacosta et al, 2002). Recent studies have shown that
neural networks can be successfully used for analysis of
dermatoscopic images (Rubegni et al, 2002a; 2002b).
Here we have developed a neural network system for the
automated classification of Raman spectra, allowing us to
differentiate MM from other clinically similar skin tumors.
First, all Raman spectra were preprocessed (see Patients
and Methods). Then, examples of Raman spectra were
used to train the neural network for learning the spectral
patterns. The performance of the neural network was tested
on an independent set of spectra, by prediction of lesion
type and comparing it to the true class. Moreover, the
importance of specific spectral bands for the classification
of individual classes could be evaluated, thus making it
possible to extract the most meaningful parts of spectra
important for the neural network classification.
Results
Spectra of normal skin The spectra of normal skin were
similar to those previously reported (Barry et al, 1992;
Edwards et al, 1995; Gniadecka et al, 1998b; 1998c). Peaks
originating from vibrations within protein molecules and
lipids were clearly resolved (Fig 1, Table I). In normal skin the
positions of the amide I and III bands (1650 cm1 and 1270
cm1) and the presence of a well-developed band around
935 cm1 suggested a helical protein structure. Pigmenta-
tion increased the background level of the spectra, which
was most pronounced in the region 1800–2500 cm1 as
previously described for normal skin (Knudsen et al, 2002)
(Fig 2). This region does not contain protein and lipid bands.
Skin tumor spectra reveal protein and lipid alterations
Spectra revealed clear-cut changes between the investi-
gated types of tumors allowing differentiation of MM from
other investigated lesions (Fig 1, Tables I, II). MM presented
with a decrease in the amide I band intensity resulting in
flattening of the spectral area between 1500 cm1 and 1800
cm1 (Fig 1A, Table II). This suggested a change in mole-
cular composition of proteins. Moreover, an increase in
intensity of the band at 1300 cm1 of the CH twisting and
wagging in lipids and the band around 1310–1330 cm1
was seen with a relative decrease in the amide III regions of
proteins (Fig 1B, Table II).
BCC showed similar spectral changes in the region
1300–1340 cm1 (Fig 1B, Table II). The emerging bands in
this region were found around 1300 cm1 and 1330 cm1.
Both MM and BCC spectra showed a decrease in protein
band intensity around 940 cm1 (Fig 1C). In contrast to MM,
BCC spectra did not show any decrease in intensity of the
amide I band (Fig 1A).
SK presented with a prominent increase in intensity of
the 1300 cm1 band, making the discrimination from BCC
possible (Fig 1B). The band around 1450 cm1 reflecting
(CH2)(CH3) in lipids and proteins was shifted in MM, BCC,
and SK (Fig 1D, Table I).
Figure1
NIR-FT Raman spectra of normal skin (NOR), PN, MM, BCC, and
SK. Spectral alterations of the following major spectral bands are
shown: (A) a major decrease in intensity of the amide I band of proteins
in MM, a slight decrease of the right wing of the band in PN; (B) the
amide III band region around 1270 cm1 and an increase in the lipid-
specific region 1300–1340 cm1 in MM, BCC, and SK; (C) a decrease
of the n(CC) band around 940 cm1 in proteins in MM, BCC, and SK;
(D) a widening of the d(CH2)(CH3) in proteins and lipids in MM, BCC,
and SK. For intensity comparison all spectra were normalized to the
1450 cm1 band.
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Spectra of PN were almost identical to those of normal
skin but consistently showed a decrease in intensity in the
right wing of the amide I band (Fig 1A, Table II). This
suggested minor changes in composition or conformational
alterations in the proteins. Moreover, in the region from 1800
cm1 to 2500 cm1, an increase in intensity of the otherwise
flat spectral region was observed (Fig 2). This phenomenon
occurred most probably due to an increase in pigmentation
of the lesional skin, similar to that of highly pigmented skin
and in MM spectra.
Neural network analysis classiﬁes MM with 85% sensi-
tivity and 99% speciﬁcity Neural network analysis of
Raman spectra achieved a diagnostic sensitivity of 85%
and specificity of 99% for the diagnosis of MM (Table III).
BCC diagnosis was 97% and 98%, respectively. The
confusion map, established by the neural network, present-
ing wrongly classified skin lesions is presented in Table IV.
MM had a tendency to be misdiagnosed as BCC and PN,
whereas PN were confused with normal skin. SK was
diagnosed with 96% sensitivity and was most frequently
confused with BCC. PN were diagnosed with 78%
sensitivity.
The sensitivity map for MM in Fig 3 showed important
spectral intensities at 1620–1670 cm1, 1230–1300 cm1,
and 1430–1450 cm1, which matched the spectral differ-
entiation marked A, B, and D in Fig 1. Moreover, the
sensitivity map pointed out new frequencies not used for
visual inspection of the spectra: 2840–3000 cm1, 2000–
2350 cm1, and 1000 cm1, marked E, F, and G respectively
in Fig 2. Vibrations reflected at these spectral regions are
most probably characteristic for (E) CH stretching in
proteins and lipids (Gniadecka et al, 1998a), (F) skin
fluorescence (Knudsen et al, 2002), and (G) ring vibrations
in aromatic amino acid residues (Gniadecka et al, 1997a).
Discussion
We have demonstrated that it is possible to differentiate MM
from PN, BCC, and SK by neural network analysis of the
near-infrared Fourier transform (NIR-FT) Raman spectra.
The neural network analysis used spectral alterations
reflecting changes in composition and structure of proteins
and lipids. MM and BCC spectra showed similar patterns
but were distinctive. Intensities in the amide III regions of
proteins decreased relative to the lipid-specific bands. An
emergence of the lipid component of the d (CH2)(CH3)
accounting for shifting of the 1450 cm1 band occurred
both in BCC and MM spectra. For SK, a major increase in
intensity of the 1300 cm1 band of twisting and wagging
vibrations of lipids reflected lipid accumulation in the horny
cysts of SK.
The first Raman spectroscopy study on cancer recogni-
tion was performed on uterus, ovary, and cervix cancer
tissue where the decrease in intensity of the amide III region
was reported (Liu et al, 1992). This phenomenon has also
been observed for laryngeal cancer, where additionally
increase in the lipid bands around 1310–1340 cm1 was
found (Stone et al, 2000). The peak around 1320 cm1 can
be attributed to both collagen and nucleic acids (DNA),
more specifically to the purine bases guanine and adenine
(Stone et al, 2000). Raman spectra obtained from MM and
BCC show similar alterations in the 1310–1340 cm1 region.
Therefore it is most probable that malignant transformation
triggers similar molecular changes independently of the
tissue involved. Alterations of the amide bands in Raman
spectra are attributed to the conformational changes of
proteins. Collagen contributes predominantly to Raman
Table I. Major protein and lipid band positions of NIR-FT Raman spectra of normal skin (NOR), PN, MM, BCC, and SK
Amide I in proteins Amide III in proteins d(CH2)(CH3) in proteins and lipids
NOR 1662 (1656–1668) 1264 (1241–1287) 1451 (1449–1453)
PN 1660 (1652–1668)a 1264 (1242–1286) 1451 (1448–1454)
MM 1655 (1647–1663)a 1272 (1258–1286)a,b 1449 (1443–1455)a
BCC 1655 (1651–1659)
a 1268 (1253–1283) 1449 (1445–1453)a
SK 1653 (1649–1657)
a 1276 (1266–1286)a 1446 (1441–1451)a
Values represent means with 95% confidence intervals.
aSignificant compared to NOR.
bSignificant compared to BCC.
Figure 2
NIR-FT Raman spectra of normal skin (NOR), PN, MM, BCC, and
SK. Note the influence of the pigmentation on the 1800–2500 cm1
region.
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spectra of the skin (Johansson et al, 2000) and therefore
changes in its structure or its degradation could explain the
decrease in the amide band intensities. Collagen degrada-
tion is influenced by matrix metalloproteinases (Yoshizaki
et al, 2002). Upregulation of metalloproteinases was found
in invasive skin tumors like MM and BCC (Hofmann et al,
2000; Varani et al, 2000) but also in endometrial and
laryngeal carcinoma (Magary et al, 2000; Di Nezza et al,
2002). Cancer–stroma interactions (Ruiter et al, 2002a),
where ground substance and fibroblasts are affected, are
most probably reflected in the alterations of the protein,
lipid, and water structure detected by Raman spectroscopy
(Gniadecka et al, 2003).
This is the first report where neural network analysis of
Raman spectra has been employed for MM diagnosis. We
have previously used this method for BCC diagnosis
(Gniadecka et al, 1997a). Neural networks and other
computer methods like principal component analysis have
been successfully used as an aid in the detection of
gastrointestinal tract malignancies and breast cancer
(Hanlon et al, 2000; Christoyianni et al, 2002; Dacosta
et al, 2002). In all cancer studies including ours, the neural
network becomes subjective as it solely relies on the
expertise of the pathologic diagnosis, recognized as a
golden standard. It is possible that Raman spectroscopy
possessing the strength of the specificity of the biochemical
information may reveal early signs of cancer transformation
before any morphologic structure analysis is seen in
histopathology.
Neural network analysis based only on the spectral
information allowed us to diagnose MM with a sensitivity of
85% and a specificity was 99%. This is comparable to the
diagnostic accuracy for MM achieved by trained specialists
in dermatology (Cassileth et al, 1986; Morton and Mackie,
1998; Chen et al, 2001). A recent study, using a similar
neural network architecture trained on features extracted
from digitized dermatoscopic images, obtained 75%
sensitivity for MM (Hintz-Madsen et al, 2001). Other recent
studies (Piccolo et al, 2002; Rubegni et al, 2002a; 2002b),
also using dermatoscopic features and neural networks,
have shown an extremely good performance. The sensitivity
was 92%–94% for MM, but these studies do not appear to
apply fully independent test data.
The neural network presented here has the advantage
that the parameter optimization does not rely on cross-
validation or tuning of parameters. Moreover, the important
input features (Raman frequencies) can be estimated
directly from the optimized neural network. Interestingly,
the neural network sensitivity map showed that the
computer system had used identical spectral bands to
those usually used for visual spectra differentiation. Altera-
tions in bands not previously perceived on visual inspection
were 2840–3000 cm1 and 1000 cm1, suggesting mole-
cular changes in CH stretching in proteins and in aromatic
side chains.
At the present stage of technical development it is
possible to obtain Raman spectra directly from the skin
surface in vivo, but the quality and reproducibility of spectra
is lower than that yielded in skin biopsies in vitro. For this
reason we included here the in vitro data only. Obviously, in
vivo Raman spectroscopy is going to play an increasingly
important role, as exemplified by a recent study on
Table II. Major band ratios in NIR-FT Raman spectra of normal skin (NOR), PN, MM, BCC, and SK
Amide I in proteins, I1650 cm1/I1450 cm1 Amide III in proteins, I1270 cm1/I1320 cm1 C–C in proteins, I930 cm1/I1000 cm1
NOR 0.69 (0.54–0.84) 1.15 (0.96–1.34) 2.49 (1.24–3.74)
PN 0.62 (0.39–0.85)a 1.05 (0.98–1.12)a 2.24 (0.64–3.84)a
MM 0.29 (0.27–0.85)a,b 0.99 (0.93–1.05)a,b 0.77 (0.29–1.83)a
BCC 0.86 (0.51–1.21)a 0.94 (0.86–1.02)a 0.82 (0.10–1.54)a
SK 0.81 (0.33–1.29)a 0.95 (0.82–1.08)a 0.85 (0.14–1.56)a
Values represent means with 95% confidence intervals
aSignificant compared to NOR.
bSignificant compared to BCC.
Table III. Speciﬁcity and sensitivity of neural network analysis
of Raman spectra for classiﬁcation of normal skin (NOR),
PN, MM, BCC, and SK
Sensitivity Speciﬁcity
NOR 96%  3 94%  3
PN 78%  6 97%  2
MM 85%  5 99%  1
BCC 98%  2 98%  2
SK 96%  3 100%  0
Sensitivity and specificity are defined as in Altman (1991) and are
shown  twice the SD of the approximated normal distribution to the
binomial distribution.
Table IV. Confusion map of the neural network predictions of
normal skin (NOR), PN, MM, BCC, and SK
NOR PN MM BCC SK
NOR 96% 20% 0% 0% 0%
PN 3% 78% 10% 2% 0%
MM 0% 2% 85% 0% 0%
BCC 1% 0% 5% 98% 4%
SK 0% 0% 0% 0% 96%
The top row indicates the correct labels, and the far left column
(marked with asterisks) indicates network predictions. The confusion map
presents the probability of different classes estimated by the neural
network given the true class label.
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gastrointestinal tract tumors (Shim et al, 2000). Preliminary
Raman spectroscopy studies revealed that in vivo spectra
of MM and BCC did not differ from in vitro spectra
(Gniadecka et al, 1998a). Development of Raman spectro-
scopy in vivo should ease tracking skin malignancy in
clinical practice and further detection of alterations in
protein and lipid structure may add to the understanding
of carcinogenic processes.
Patients and Methods
Skin samples Three millimeter punch biopsies of MM (n¼ 22;
including in situ, superficial spreading, and nodular melanoma) and
PN (n¼ 41), and punch biopsies or curettage specimens of BCC
(n¼ 48; including nodular and superficial spreading types), SK
(n¼ 23), and normal skin (n¼ 89; biopsies of the skin in the vicinity
of the lesions from various body regions) were collected for Raman
spectroscopy. The samples were kept atþ 41C in closed vessels
during the short period before analysis. The majority of the
samples were analyzed immediately by Raman spectroscopy.
Some of the samples were snap frozen in liquid nitrogen and
stored at 801C. The frozen samples were transferred to closed
vessels and allowed to thaw at þ 41C for 3–5 min. The Ethics
Committee of Copenhagen City, Denmark, accepted the protocol.
All patients gave informed consent in agreement with the
Declaration of Helsinki Principles.
Raman spectroscopy A Bruker IFS 66 interferometer equipped
with an FRA 106 module or FRA 100 (Karlsruhe, Germany) were
used as previously described (Gniadecka et al, 1998b; 1998c). The
laser beam (1064 nm line at 300 mW from a continuous wave
Nd:YAG laser) was focused to a spot of approximately 100 mm
diameter on the epidermal site of the biopsy or curetted speci-
mens, which during the procedure were placed in a stainless-steel
cup. Typically 250 scans at a 4 cm1 spectral resolution were
collected from each sample over approximately 7 min. In preli-
minary experiments we found no significant overheating or thermal
injury of the samples in these conditions (unpublished). Zero-filling
was used for all spectra. OPUS software (Bruker) was used to
evaluate spectral characteristics in the region from 200 cm1 to
3500 cm1. Before the visual evaluation, the spectra were
normalized for the 1450 cm1 band intensity in the 800–1800
cm1 region and for the 2940 cm1 band intensity in the 2500–
3500 cm1 region. The intensity of the 1450 cm1 and 2940 cm1
bands remain stable under a variety of conditions and have
therefore been routinely chosen for spectra normalization by us
and numerous other researchers. For neural network analysis the
spectral region from 200 cm1 to 3500 cm1 was used.
Spectra evaluation To analyze alterations in protein and lipid
structure, the positions, shape, and intensity of spectral bands for
proteins, lipids, and water were studied in the region 1200–1750
cm1. This area comprises the major protein and lipid vibrations.
Among seven important protein vibrations, the amide I and amide
III vibrations are clearly represented in Raman spectra of the skin
(Edwards et al, 1995). The amide I band (around 1650 cm1)
reflects mainly C¼O stretching vibrations, whereas the amide III
band (around 1270 cm1) is a more complex mode involving
several chemical bonds. Combined maximum intensity frequencies
of the amide I and III bands reflect protein secondary structure (a-
helix conformation, b-sheet, random coil). Moreover, a CC stretch
band at approximately 935 cm1 is typical for an a-helix. Lipid-
specific vibrations are found around 1300 cm1 (twisting and
wagging vibrations) and in the region extending to 1340 cm1
(Edwards et al, 1995).
The intensities of the described spectral bands were calculated
using Matlab software (The MathWorks, USA). To demonstrate
spectral changes for proteins, the ratio between the amide I band
and d(CH2)(CH3) in proteins and lipids (I1650 cm1/I1450 cm1) and the
ratio between the amide III and lipids at around 1320 cm1 were
calculated (I1270 cm1/I1320 cm1) (Tables I, II).
Neural network analysis The raw Raman spectra were fed to the
system where they were preprocessed. The preprocessing stage
included background suppression1 and dimension reduction2 of
the spectrum. Based on the preprocessed spectrum, the neural
network predicted the probability that a spectrum belonged to the
lesion types.3 The spectra were assigned to the class that had the
highest predicted class probability. Before the system could be
used for classification, the weights (parameters) of the neural
network were trained (optimized) from a set of spectra with class
labels.4 The training needed careful control to avoid over-fitting5
the training data, as the neural network architecture used here was
extremely flexible and able to fit the data with arbitrary accuracy.
The neural network classifier software was written in Matlab
and is freely available at http://mole.imm.dtu.dk/toolbox/ann/
index.htmL.
Figure 3
The sensitivity map of neural network weighting of spectral
frequencies, used for MM classification. The dashed line indicates
the 99% confidence interval. Spectral bands marked (A), (B), (D)
correspond to the description from Fig 1 showing differences detected
on visual classification of the spectra. (E) CH3 stretching vibrations in
proteins and lipids (around 2940 cm1); (F) vibration caused by skin
fluorescence (2000–2350 cm1); (G) ring vibrations in amino acids
(around 1000 cm1).
1The background suppression was obtained by numerically
computing the local first derivative of each spectrum.
2The number of dimensions is reduced with principal compo-
nents analysis of the data and by removing the least significant
principal components. The number of retained principal compo-
nents was determined with the Bayesian information criterion,
using the maximum likelihood formulation of the principal
components analysis (Hansen and Larsen, 1996).
3The neural network architecture was based on the feedforward
architecture with two layers of weights and hyperbolic tangent
function as activation function of the hidden units. To interpret the
output of the neural network as probabilities, the outputs were
extended with an exponential transformation called softmax.
4The weight optimization was done by a quasi-Newton scheme,
described in detail in Nielsen (2000).
5The approach adapted here used regularization and outlier
detection to prevent over-fitting. A Bayesian ML-II approximation
was used to estimate a regularization parameter and outlier
probability (Sigurdsson et al, 2002).
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The importance of specific spectral bands for the neural
network classification was evaluated with sensitivity analysis.6
The results are visualized with sensitivity maps, where high
sensitivity of a specific spectral band was interpreted as highly
important for the neural network classification. The NPAIRS
framework7 was used to determine the reproducibility of the
sensitivity maps. By using this framework, confidence intervals
were determined for the sensitivity maps to reflect their reprodu-
cibility. Sensitivity maps that are highly reproducible have
correspondingly high confidence.
All spectra were examined at frequencies from 200 cm1 to
3500 cm1 at a spectral resolution of around 2 cm1 (zero-padded
original spectrum). By using the preprocessing method, the
dimension of the spectra was reduced from the original 1711
frequency components to seven inputs to the neural network. The
seven inputs matched the first seven principal components.
The neural network had initially seven input units, 20 hidden
units, and five output units, one for each class. The generalization
capability of the network was tested with leave-one-out cross-
validation, where a single example is used for testing and all others
for training. This was done for all examples. The dimension
reduction was calculated on the training set and then applied on
the test set, so that the test data were truly independent of the
training data. After training, the optimal neural network was
evaluated using the test set and the classification errors were
calculated. The reported specificity and sensitivity for each of the
classes was determined based on the average of the five leave-
one-out cross-validations.
A sensitivity analysis was performed in order to obtain
information about the relevant frequency bands in the Raman
spectra for each class. The reported average sensitivity map with
confidence interval for MM was obtained from the average of 100
pairs of sensitivity maps using the NPAIRS framework.
Statistical analysis Data were not normally distributed and
therefore the nonparametric Wilcoxon test was used to compare
the values. Confidence intervals were calculated as described by
Altman (1991). p  0.05 was considered significant.
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